Page 183 - FINAL PROGRAM

P-697 Fertility outcomes following single ideal blastocyst transfers in women less than 40 years of age as a function of ovarian reserve
A. Zakhari (Canada)
P-698 The ultrasonographic “black crown”: a new ovarian aspect pathognomonic of altered follicular ovarian status in infertile women
M. Valiere (France)
P-699 Levothyroxine replacement therapy for infertile patients with Hashimoto’s disease may improve serum Anti-Müllerian hormone levels
M. Kuroda (Japan)
P-700 AMH levels variations during treatment with GnRh agonist: A prospective observational study
R. Mocciaro (Italy)
P-701 No evidence for lower serum AMH levels in female BRCA1/2 mutation carriers
C. van Tilborg (The Netherlands)
P-702 Neurokinin B receptor antagonism suppresses ovarian follicle growth and delays ovulation in healthy women
R. Anderson (United Kingdom)
P-703 Do not dismiss the long downregulation protocol for women at risk of ovarian hyperstimulation syndrome (OHSS)
A. Papathanasiou (United Kingdom)
P-704 The mechanism research on hyperhomocysteinemia-associated insulin resistance in polycystic ovary syndrome patients
B. Zhang (China)
P-705 Low dose human chorionic gonadotropin as an adjuvant to GnRHa for nal oocyte maturation rescues the poor outcome of suboptimal responders to GnRHa
Y. Kuang (China)
P-706 Intramuscular versus vaginal progesterone administration in medicated IVF frozen embryo transfer (FET) cycles: a randomised clinical trial
A. Hershko Klement (Israel)
P-707 Assessment of endometrial thickness in women with luteinizing hormone de ciency undergoing ovulation induction
E. Burt (United Kingdom)
P-708 Identi cation of altered microRNAs and mRNAs in cumulus cells of PCOS patients: miRNA-509-3p promote estradiol secretion by targeting MAP3K8
X. Huang (China)
P-709 Mechanism of androgen excess inducing neuroendocrine disorders in female rats and dysfunction of GnRH secretion in GT 1-7 cell
C. Yuan (China)
FINAL PROGRAMME I HELSINKI, FINLAND – 3 TO 6 JULY 2016 179
POSTERS